One of the hottest startups in the AI-generated drug discovery landscape has corralled $400 million in a Series C that triples its paper value from its last round of financing.

Chai Discovery is raising $400M at a $3.4B valuation for AI drug discovery, backed by Pfizer, Eli Lilly, and OpenAI, raising questions for crypto's DeSci

One of the hottest startups in the AI-generated drug discovery landscape has corralled $400 million in a Series C that triples its paper value from its last round of financing.